Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.81 |
| ▸ | CNR1 | P21554 | 12/20 | 0.81 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.81 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.81 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.81 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.81 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.81 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.76 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.76 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.76 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.76 |
| ▸ | HTR2A | P28223 | 1/20 | 0.76 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.76 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.76 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.76 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13214141 | 1.00 | CNR2 (0.81) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29360929 | 0.90 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL2671595 | 0.90 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL13214136 | 0.87 | CNR2 (0.93) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29815108 | 0.87 | CNR2 (0.93) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL23460333 | 0.86 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL121085 | 0.86 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29433714 | 0.86 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29350505 | 0.86 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29815206 | 0.86 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | FLORASCIENCE INC. | 2025-07-03 | — | — | US | disclosed |
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | FLORASCIENCE INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20240261302-A1 | METHODS OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS | FLORASCIENCE INC (US) | 2024-08-08 | — | — | US | disclosed |
| EP-4305027-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | Kare Chemical Technologies Inc. (CA) | 2024-01-17 | — | — | EP | disclosed |
| CN-117321041-A | Catalytic cannabinol synthesis and precursors | 凯尔化学科技公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2022187935-A1 | CATALYTIC CANNABINOL SYNTHESIS AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2022-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281091-B1 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
| US-20250214957-A1 | METHODS OF PREPARING CANNABINOIDS OR DERIVATIVES THEREOF | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
| US-20240261302-A1 | METHODS OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS | SNCA, HTT, NLN | CNR2 9/4885CNR1 11/4885TRPA1 2020/4885 |
| US-12371412-B2 | Methods of preparing cannabinoids or derivatives thereof | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPA1 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.